News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
330 Results
Type
Article (7)
Company Profile (1)
Press Release (322)
Section
Business (65)
Deals (12)
Drug Development (103)
FDA (5)
Job Trends (3)
News (195)
Policy (26)
Tag
Academia (1)
Alliances (15)
Approvals (5)
Best Places to Work (1)
Biotechnology (1)
Cell therapy (1)
Clinical research (90)
Collaboration (1)
Earnings (27)
Events (37)
FDA (6)
Funding (1)
GLP-1 (1)
Intellectual property (1)
IPO (5)
Job creations (2)
Legal (1)
Manufacturing (1)
Mergers & acquisitions (7)
NextGen: Class of 2026 (2)
Patents (1)
People (21)
Phase 1 (7)
Phase 2 (49)
Phase 3 (37)
Pipeline (1)
Postmarket research (3)
Preclinical (9)
Regulatory (27)
Research institute (1)
Series B (1)
Startups (3)
Vaccines (3)
Date
Last 365 days (8)
2026 (1)
2025 (7)
2024 (11)
2023 (8)
2022 (7)
2021 (12)
2020 (10)
2019 (8)
2018 (7)
2017 (22)
2016 (18)
2015 (24)
2014 (24)
2013 (38)
2012 (35)
2011 (31)
2010 (27)
Location
Asia (12)
Australia (3)
California (2)
China (1)
Europe (24)
Massachusetts (1)
Nevada (1)
Pennsylvania (1)
South America (1)
Southern California (2)
United States (8)
Washington State (4)
330 Results for "bonum therapeutics.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
USPTO Grants Key Mechanism of Action Patent to Bonum Therapeutics for its Conditionally Active Biologics Technology
August 14, 2025
·
3 min read
Press Releases
Bonum Therapeutics to Participate in Panel on Conditionally Active Biologics at BIO 2025
June 10, 2025
·
3 min read
BioForest
Bonum Therapeutics to Present Poster on Lead Program at AACR 2024
Bonum Therapeutics announced the first public presentation of preclinical data on its lead program, a conditionally active LAG3-IL2 therapeutic.
March 5, 2024
·
3 min read
BioForest
Bonum Therapeutics to Present on its Novel Platform for Generating Conditionally Activated Targeted Therapies at Keystone Conference
Bonum Therapeutics today announced that it will present data on a new class of protein therapeutics with the potential for increased safety and efficacy in a wide range of biologic targets and disease areas.
April 29, 2024
·
4 min read
Press Releases
Bonum Therapeutics Appoints Samuel C. Blackman, MD, PhD, to its Board of Directors
December 3, 2024
·
3 min read
Business
Good Therapeutics’ Offshoot Bonum Launches with $93 Million in Series A (Updated)
Two months after selling an immuno-oncology platform developed by Good Therapeutics to Roche, Bonum Therapeutics launched Tuesday with $93 million in Series A financing.
November 15, 2022
·
2 min read
·
Alex Keown
BioForest
Bonum Therapeutics Announces a $93M Series A Financing to Advance a Novel and Validated Class of Conditionally Active Therapies
Bonum Therapeutics today announced a $93 million Series A financing.
November 15, 2022
·
3 min read
BioMidwest
TRxADE Group Announces Strategic Telehealth Partnership with Brookshire Grocery Company
TRxADE Telehealth Subsidiary Bonum Health to Provide Affordable Telemedicine Services to Patients at Leading Grocery Store Chain
May 6, 2021
·
6 min read
Press Releases
Mediar Therapeutics Announces Oversubscribed $76 Million Series B Financing and Clinical Advancement of First-in-Class Fibrosis Portfolio
January 7, 2026
·
5 min read
Bonum Therapeutics
Bonum Therapeutics is focused on a proven technology that utilizes regulation to create targeted, highly active, and less toxic medicines.
1 of 33
Next
